Drug Trial Radar · NCT06060665
Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)
Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Sep 5, 2023
Primary completion
May 6, 2026
Study completion May 6, 2026
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- First posted
- Sep 29, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA). The primary objective is to evaluate the effect of seladelpar treatment at Week 52 compared to placebo based on normalization of alkaline phosphatase (ALP) defined by a composite endpoint of ALP ≤ 1.0× upper limit of normal (ULN) and ≥ 15% decrease from baseline in PBC participants with an ALP value greater than ULN but less than 1.67× ULN.
Conditions
- Primary Biliary Cholangitis
Interventions
Seladelpar 10 mgDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Response defined as Alkaline phosphatase (ALP) ≤ 1.0× Upper Limit of Normal (ULN) AND ≥ 15% Decrease in ALP at Week 52.Time frame: 52 weeks
- Type, Frequency, and Severity of Treatment-emergent Adverse Events.Time frame: 52 weeks
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health
Chandler, Arizona
California Liver Research Institute
Pasadena, California
University of California (UC) Davis Medical Center
Sacramento, California
California Pacific Medical Center
San Francisco, California
University of Colorado Denver - School of Medicine - Anschutz Medical Campus
Aurora, Colorado
South Denver Gastroenterology
Englewood, Colorado
Florida Research Institute
Lakewood Rch, Florida
University of Miami - Schiff Center for Liver Diseases
Miami, Florida
Gastro Health Research
Miami, Florida
Covenant Metabolic Specialists, LLC
Sarasota, Florida
Covenant Metabolic Specialists, LLC
Tampa, Florida
Digestive Healthcare of Georgia
Atlanta, Georgia
Northwestern Medicine Clinical Research Unit (CRU)
Chicago, Illinois
Tulane University Medical Center
New Orleans, Louisiana
Louisiana Research Center, LLC
Shreveport, Louisiana
Mercy Medical Center - Baltimore, Maryland
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Henry Ford Health System
Novi, Michigan
University of Minnesota
Minneapolis, Minnesota
Kansas City Research Institute
Kansas City, Missouri
New-York-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York
Northwell Health Center for Liver Disease and Transplantation
Manhasset, New York
New York University (NYU) Langone Medical Center
New York, New York
Weill Cornell Medicine
New York, New York
University of Rochester Medical Center - Strong Memorial Hospital
Rochester, New York
Gastro Health Research
Liberty Township, Ohio
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania
UPMC Center for Liver Health
Pittsburgh, Pennsylvania
OGI - Gastro One
Cordova, Tennessee
Galen Hepatology
Hixson, Tennessee
Gastrointestinal Associates of Northeast Tennessee, P.C.
Johnson City, Tennessee
American Research Corporation - San Antonio, TX
Austin, Texas
The Liver Institute at Methodist Dallas Medical Center
Dallas, Texas
Liver Center of Texas
Dallas, Texas
University of Texas Southwestern Medical Center
Dallas, Texas
Soma Clinical Trials, LLC
Denison, Texas
Baylor College of Medicine - Baylor Clinic
Houston, Texas
Liver Associates of Texas, P.A.
Houston, Texas
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.